Haematology Cancer Care (HCC) is the charitable arm of the Blood Diseases (clinical haematology) service at UCLH, the largest of its kind in Europe with more than 200 specialist nursing staff, nearly 30 consultants and a large multidisciplinary team of expert support staff. The charity brings together haematology patients, families, supporters and staff to raise funds for the service. It uses the money to improve the experience of haematology patients and their families at UCLH, providing vital medical equipment, additional training for staff and complementary therapies for patients and families.
Professor David Linch, Head of the department of haematology and chairman of the Cancer Research UK Cancer Centre says, “HCC’s funding (of vital equipment and sponsorship of a PhD student) has helped the T-Cell project proceed (using genetically modified T-Cells to treat Leukaemia, Lymphoma and Myeloma in a new way) and helped UCLH attract two major awards (from the Department of Health and the Wellcome Trust) measured in millions of pounds to take this work forward with our patients”.
Daniel Putensen, Staff Nurse at Apheresis Bay says, “Haematology Cancer Care has provided three apheresis machines (used for myeloma and red cell patients and stem cell transplants) and an ultrasound device, making the apheresis experience less stressful and helping UCLH to save money”.
Dr Mike Watts, Director at Wolfson Cellular Therapy Unit says, “thanks to the support of HCC the laboratory can maintain a reliable and rapid service for patients undergoing treatment at UCLH and continue with exciting new research in the field of cancer care”.
HCC introduced free complementary therapy to haematology and continues to fund the service which is available free to patients and their families. "There is a great deal of reassurance explaining in plain and simple language that our therapy service is designed to support the effects of blood disorders and their treatment, which includes stress, anxiety, sleep issues, digestive issues, aches and pains and to provide general relaxation and wellbeing. Thank you to HCC for your long-term funding for our complementary therapy services at UCLH." - Chris Gibbs, Complementary Therapist.
"Without this we compromise the process of continuous learning that is the trademark of healthcare professionals, and ultimately help enable that very real fear of perhaps not knowing as much as we could." - Simon Clare, Practice Development Lead, Haematology.
Suzy Day, first graduate of the new haematology oncology rotation programme, 2017, funded by HCC says, "The haematology oncology rotation has taught me how to better support my patients’ needs by encouraging self-learning and increasing my knowledge of different conditions".
"The MACSQuant is a great asset for transplantion patient management and cell testing research. The scientists in the WCTU can happily confirm that it is providing a speedy service for transplantation patients which is much appreciated by the apheresis nurses and once more thank the generous support of the HCC charity donors for making this possible." - Dr Mike Watts, Director Wolfson Cellular Therapy Unit (WCTU).
Professor David Linch, Head of the department of haematology and chairman of the Cancer Research UK Cancer Centre says, “HCC’s funding (of vital equipment and sponsorship of a PhD student) has helped the T-Cell project proceed (using genetically modified T-Cells to treat Leukaemia, Lymphoma and Myeloma in a new way) and helped UCLH attract two major awards from the Department of Health and the Wellcome Trust, measured in millions of pounds to take this work forward with our patients.”
These are just some of the ways in which we support the patient experience within haematology at UCLH. Read the latest HCC newsletter to find out more.
Support HCC this Christmas by buying Christmas cards or entering the raffle. Just print off the order form and send to 4th Floor UCH, 235 Euston Road, London NW1 2BU.
For more information please contact:
T: 020 3447 9526